Blood Pressure
Conditions
Brief summary
The primary objective of this research is to collect data to develop an algorithm for continuous, non-inflating measurement of absolute, long-term Blood Pressure using the CS6BP device and to evaluate the safety of the CS6BP.
Detailed description
The study will take place in the ICU (Intensive Care Unit) on non-anesthetized subjects with an arterial line inserted into the radial artery. The CS6BP non-invasive continuous recording will be collected parallel to an invasive arterial line recording. ECG data that was recorded in the ICU will be collected as well. The study will include up to 80 subjects. The subject may be measured by the CS6BP device more than once to check reproducibility. The first measurement may take up to 24h; Subsequent measurements may take up to 5h. All the data analysis will be done offline.
Interventions
DEVICEArterial LIne
Continuous non-invasive recording of CS6BP will be taken parallel to the recording of an invasive arterial line. ECG data recorded in the ICU will also be collected.
Sponsors
CardiacSense Ltd.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Intervention model description
Non-anaesthetized subjects in the ICU (Intensive Care Unit) or in the CICU (Cardiac Intensive Care Unit) with arterial line placement in the radial artery.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age of eighteen (18) year and above * Ability and willingness to sign an informed consent form * Monitored by radial arterial line
Exclusion criteria
* Subjects with hemodynamic support * Subjects receiving more than 2-3 l of fluid per 24h * Subjects with septic shock * Subjects with distal edema * Subjects with arms trauma, where the watch is not wearable * Subjects where the radial artery could not be palpate * Subjects with life expectancy of less than 24h. * Subjects who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the subject's participation in this study * Any concomitant condition which, in the opinion of the investigator, would not allow safe participation in the study (e.g. drug addiction, alcohol abuse, emotional/psychological diagnosis)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety of CardiacSense 1BP: Incidence and severity of device related Adverse Events | measurement time (up to 24 hours) | Incidence and severity of device related Adverse Events |
| Collection of data from CardicacSense1BP measurements for algorithm development | measurement time (up to 24 hours) | CardicacSense1BP data will be collected in parallel with blood pressure data from ICU a- line . |
Countries
Israel
Contacts
Primary ContactBenita Lanzer
Backup ContactLiat Shemesh
Outcome results
None listed